Related Experiment Video
Updated: Sep 8, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
miRNAs and the Hippo pathway in cancer: Exploring the therapeutic potential (Review)
Taruna Arora1, Mohd Adnan Kausar2, Shimaa Mohammed Aboelnaga3
1Division of Reproductive Biology, Maternal & Child Health, Department of Health Research, ICMR, MOHFW, Government of India, Ansari Nagar, New Delhi 110029, India.
Abstract:
Cancer is recognized as the leading cause of death worldwide. The hippo signaling pathway regulates organ size by balancing cell proliferation and cell death; hence dysregulation of the hippo pathway promotes cancer‑like conditions. miRNAs are a type of non‑coding RNA that have been shown to regulate gene expression. miRNA levels are altered in various classes of cancer. Researchers have also uncovered a crosslinking between miRNAs and the hippo pathway, which has been linked to cancer. The components of the hippo pathway regulate miRNA synthesis, and various miRNAs regulate the components of the hippo pathway both positively and negatively, which can lead to cancer‑like conditions. In the present review article, the mechanism behind the hippo signaling pathway and miRNAs biogenesis and crosslinks between miRNAs and the hippo pathway, which result in cancer, shall be discussed. Furthermore, the article will cover miRNA‑related therapeutics and provide an overview of the development of resistance to anticancer drugs. Understanding the underlying processes would improve the chances of developing effective cancer treatment therapies.
Insights
The hippo signaling pathway and microRNAs (miRNAs) are crucial in cancer development. Understanding their complex interplay offers new avenues for effective cancer therapeutics and overcoming drug resistance.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer is a leading global cause of death, often linked to cellular dysregulation.
- The hippo signaling pathway controls organ size by regulating cell proliferation and apoptosis.
- MicroRNAs (miRNAs), non-coding RNAs, are implicated in various cancers and regulate gene expression.
Purpose of the Study:
- To elucidate the intricate mechanisms of the hippo signaling pathway and miRNA biogenesis.
- To explore the cross-regulatory links between miRNAs and the hippo pathway in cancer.
- To review miRNA-based therapeutics and the challenge of anticancer drug resistance.
Main Methods:
- Literature review focusing on molecular mechanisms.
- Analysis of the interplay between hippo pathway components and miRNA regulation.
- Synthesis of current research on miRNA therapeutics and drug resistance.
Main Results:
- Dysregulation of the hippo pathway can lead to cancer-like conditions.
- miRNAs and the hippo pathway exhibit complex cross-regulatory interactions.
- Altered miRNA expression is a hallmark of various cancer types.
Conclusions:
- Understanding the hippo pathway-miRNA axis is vital for cancer biology.
- Targeting miRNAs presents a promising therapeutic strategy for cancer treatment.
- Addressing drug resistance mechanisms is essential for improving patient outcomes.
More Related Videos
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Related Concept Videos
Non-Canonical Wnt Signaling Pathways
MicroRNAs
Canonical Wnt Signaling Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...
Hedgehog Signaling Pathway
Abnormal Proliferation